Clinical Trial Update: Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tolvaptan versus fluid restriction in hospitalized patients with dilutional hyponatremia was terminated; results were posted in October…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia
• Syndrome of Inappropriate Antidiuretic Hormone Secretion

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Hyponatremia, Dilutional Hyponatremia | Phase 3 | Status: TERMINATED | Results posted: 2014-10-17